This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Print Page   |   Contact Us   |   Sign In   |   Register
Community Search
WCBP 2020
Share |


 

The WCBP Symposium series was created to address issues at the interface of CMC development and global regulatory for biotechnology-derived health intervention products. The goal of this Symposium series is to provide a forum for discussing the latest technical challenges and development strategies for products ranging from proteins, vaccines, blood products, biosimilars, and cell and gene therapies. In addition, it is an opportunity to discuss how to accelerate patient-centric drug development and to increase global access in the digital age. The topics span end-to-end development from molecule selection to post-approval changes using both state-of-the-art innovations, as well as conventional technologies. Topics include but are not limited to molecule selection, bioprocess development, analytical characterization, formulation development, CQA's and control strategies, validation approaches, comparability and use of advance analytics. 

 

 
 

Want more information? Check out the "More in this Section" dropdown box at the top of the page!
Or contact CASSS at 510-428-0740 or info@casss.org


WCBP 2020 is co-sponsored by the US Food and Drug Administration


 

 

Membership Software Powered by YourMembership  ::  Legal